circFoxp1 is an oncogene in EOC cells and can confer DDP resistance to EOC cells. Circulating exosomal circFoxp1 can be used as a biomarker and potential therapeutic target for EOC.
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.